Belite Bio Overview
Belite Bio Target Price
Where could BLTE trade next? Consensus target price: $240.
Get informed when a big investor buys or sells
+ FollowShare Price
$147.33
Average Target Price
$241.71
64.1% upside
64.1% upside7 analysts in the last 4 months
High: $303 | Low: $206
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-09 | Mizuho SecuritiesGraig Suvannavejh | $234 | 58.8% upside |  |
| 2026-09-08 | H.C. Wainwright | $245 | 66.3% upside | |
| 2026-09-04 | Canaccord Genuity | $303 | 105.7% upside | |
| 2026-08-14 | Morgan Stanley | $206 | 39.8% upside | |
| 2026-08-14 | Cantor FitzgeraldSteve Seedhouse | $270 | 83.3% upside | |
| 2026-08-14 | Mizuho SecuritiesGraig Suvannavejh | $220 | 49.3% upside | |
| 2026-08-12 | H.C. WainwrightYi Chen | $214 | 45.3% upside | |
| 2026-05-26 | Mizuho SecuritiesGraig Suvannavejh | $215 | 45.9% upside | |
| 2026-05-22 | Truist Financial | $217 | 47.3% upside | |
| 2026-03-04 | H.C. WainwrightYi Chen | $200 | 35.7% upside | |
| 2026-03-03 | Needham | $217 | 47.3% upside | |
| 2026-02-19 | Mizuho SecuritiesGraig Suvannavejh | $223 | 51.4% upside | |
| 2026-01-06 | Morgan Stanley | $191 | 29.6% upside | |
| 2025-12-03 | BTIG | $187 | 26.9% upside | |
| 2025-12-02 | Maxim Group | $200 | 35.7% upside | |
| 2025-12-02 | Mizuho SecuritiesGraig Suvannavejh | $194 | 31.7% upside | |
| 2025-12-01 | H.C. Wainwright | $185 | 25.6% upside | |
| 2025-11-20 | Mizuho Securities | $105 |  28.7% downside | |
| 2024-08-13 | H.C. WainwrightYi Chen | $60 | 59.3% downside | |